Showing results (31-40 of 48) with videos related to
Sort By:
Pageof 5
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2000
Patients treated with antitumor drugs displaying neurological deficits are characterized by a low circulating level of nerve growth factorS De Santis, A Pace, L Bove, et al.Anticancer Research|May 16, 2000
Single agent docetaxel plus granulocyte-colony stimulating factor (G-CSF) in previously treated patients with advanced non small cell lung cancer. A phase II study and review of the literatureC Gridelli, L Frontini, E Barletta, et al.British Journal of Cancer|January 5, 2001
Carboplatin plus paclitaxel in extensive small cell lung cancer: a multicentre phase 2 studyC Gridelli, L Manzione, F Perrone, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 26, 2005
Weekly paclitaxel as first-line chemotherapy in elderly advanced breast cancer patients: a phase II study of the Gruppo Italiano di Oncologia Geriatrica (GIOGer)L Del Mastro, F Perrone, L Repetto, et al.Oncology Reports|January 12, 2005
Randomised, open-label, phase II trial of paclitaxel, gemcitabine and cisplatin versus gemcitabine and cisplatin as first-line chemotherapy in advanced transitional cell carcinoma of the urotheliumVito Lorusso, Enrico Crucitta, Nicola Silvestris, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 26, 2007
Adjuvant chemotherapy with epirubicin, leucovorin, 5-fluorouracil and etoposide regimen in resected gastric cancer patients: a randomized phase III trial by the Gruppo Oncologico Italia Meridionale (GOIM 9602 Study)F De Vita, F Giuliani, M Orditura, et al.Gynecologic Oncology|March 26, 1998
Combined carboplatin plus ifosfamide and cisplatin in patients with advanced ovarian carcinoma. A phase I-II study. GOCS (Gynecological Oncology Cooperative Study)V Lorusso, B Leone, G Di Vagno, et al.Clinical Lung Cancer|January 22, 2004
Interim analysis of a phase III trial comparing cisplatin, gemcitabine, and vinorelbine vs. either cisplatin and gemcitabine or cisplatin and vinorelbine in advanced non small-cell lung cancer. A Southern Italy Cooperative Oncology Group StudyP Comella, N Panza, L Manzione, et al.JAMA Otolaryngology-- Head & Neck Surgery|November 4, 2021
Prevalence and Risk Factors for Multifocality in Pediatric Thyroid CancerGrace L Banik, Maisie L Shindo, Kristen L Kraimer, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1999
Cisplatin, gemcitabine, and vinorelbine combination therapy in advanced non-small-cell lung cancer: a phase II randomized study of the Southern Italy Cooperative Oncology GroupP Comella, G Frasci, N Panza, et al.Pageof 5